Index S&P 500
P/E 67.90
EPS (ttm) 1.24
Insider Own 0.43%
Shs Outstand 1.47B
Perf Week 0.73%
Market Cap 123.58B
Forward P/E 30.70
EPS next Y 2.73
Insider Trans -7.54%
Shs Float 1.47B
Perf Month 6.48%
Income 1.83B
PEG 5.29
EPS next Q 0.59
Inst Own 91.62%
Short Float 0.75%
Perf Quarter 7.99%
Sales 15.23B
P/S 8.12
EPS this Y 17.48%
Inst Trans 0.92%
Short Ratio 1.96
Perf Half Y 24.22%
Book/sh 13.85
P/B 6.06
EPS next Y 13.49%
ROA 5.16%
Short Interest 11.02M
Perf Year 55.12%
Cash/sh 2.03
P/C 41.36
EPS next 5Y 12.84%
ROE 9.46%
52W Range 48.35 - 84.89
Perf YTD 45.17%
Dividend Est. -
P/FCF 67.13
EPS past 5Y -2.05%
ROI 6.15%
52W High -1.14%
Beta 0.80
Dividend TTM -
Quick Ratio 1.14
Sales past 5Y 8.10%
Gross Margin 62.04%
52W Low 73.57%
ATR (14) 1.36
Dividend Ex-Date -
Current Ratio 1.61
EPS Y/Y TTM 108.08%
Oper. Margin 16.46%
RSI (14) 67.85
Volatility 1.73% 1.52%
Employees 48000
Debt/Eq 0.54
Sales Y/Y TTM 13.64%
Profit Margin 12.00%
Recom 1.46
Target Price 88.28
Option/Short Yes / Yes
LT Debt/Eq 0.46
EPS Q/Q 21.82%
Payout 0.00%
Rel Volume 1.24
Prev Close 83.71
Sales Surprise 2.26%
EPS Surprise 6.27%
Sales Q/Q 14.48%
Earnings Jul 24 BMO
Avg Volume 5.63M
Price 83.92
SMA20 2.70%
SMA50 6.91%
SMA200 19.45%
Trades
Volume 6,966,878
Change 0.25%
Date
Action
Analyst
Rating Change
Price Target Change
May-30-24 Initiated
Goldman
Buy
$90
Feb-01-24 Upgrade
Mizuho
Neutral → Buy
$65 → $80
Jul-19-23 Initiated
Robert W. Baird
Outperform
$59
Jun-30-23 Initiated
CL King
Buy
$64
May-30-23 Resumed
Morgan Stanley
Overweight
$58
Mar-29-23 Initiated
UBS
Buy
$57
Dec-22-22 Initiated
Mizuho
Neutral
$52
Dec-20-22 Resumed
Citigroup
Buy
$54
Oct-18-22 Initiated
Barclays
Overweight
$49
Oct-12-22 Initiated
Jefferies
Buy
$50
Jul-06-22 Initiated
Wolfe Research
Outperform
$43
May-27-22 Upgrade
Needham
Hold → Buy
$48
Apr-13-22 Resumed
Truist
Buy
$52
Mar-02-22 Resumed
BofA Securities
Buy
$55
Dec-10-21 Initiated
RBC Capital Mkts
Outperform
$51
May-26-21 Downgrade
Needham
Buy → Hold
May-25-21 Initiated
Barclays
Overweight
$51
Apr-15-21 Initiated
Atlantic Equities
Overweight
$52
Sep-17-20 Initiated
Truist
Buy
$47
Sep-11-20 Initiated
Wolfe Research
Peer Perform
$46
Show Previous Ratings
Today 12:45PM
12:00PM
11:54AM
09:30AM
09:15AM
08:02AM
Loading…
Sep-19-24 08:02AM
Sep-18-24 09:45AM
Sep-17-24 06:00PM
12:34PM
08:31AM
07:00AM
Sep-16-24 08:03PM
Sep-13-24 08:10AM
Sep-11-24 06:00PM
Sep-05-24 06:00PM
08:32AM
Loading…
08:32AM
Sep-03-24 12:57PM
Aug-30-24 06:00PM
Aug-28-24 06:00AM
Aug-27-24 11:13AM
06:57AM
Aug-23-24 11:30AM
Aug-22-24 12:45PM
Aug-21-24 09:40AM
Aug-20-24 10:05PM
11:56AM
Aug-18-24 02:06PM
Aug-16-24 08:14AM
Aug-13-24 08:00AM
03:32AM
09:30AM
Loading…
Aug-09-24 09:30AM
Aug-06-24 12:45PM
Aug-02-24 06:00AM
05:54AM
Aug-01-24 08:36AM
Jul-31-24 12:30PM
09:50AM
Jul-30-24 04:05PM
Jul-26-24 10:30AM
(Investor's Business Daily)
Jul-25-24 12:30PM
(The Wall Street Journal)
02:58AM
(Thomson Reuters StreetEvents)
Jul-24-24 04:44PM
04:08PM
(Investor's Business Daily)
12:53PM
12:48PM
12:11PM
10:07AM
(Investor's Business Daily)
09:30AM
07:58AM
(Investor's Business Daily)
07:40AM
07:13AM
06:37AM
(Associated Press Finance)
06:30AM
03:34AM
Jul-22-24 11:38AM
05:32AM
Jul-20-24 08:45PM
Jul-17-24 10:01AM
09:40AM
Jul-16-24 11:23AM
Jul-15-24 06:00PM
Jul-11-24 06:15PM
Jul-10-24 10:13AM
Jul-03-24 10:45AM
10:23AM
Jul-02-24 10:00AM
Jul-01-24 08:00AM
Jun-28-24 06:00PM
Jun-26-24 02:11PM
11:22AM
09:55AM
Jun-25-24 07:14AM
Jun-24-24 06:15PM
09:45AM
09:13AM
07:53AM
Jun-21-24 09:00AM
(The Wall Street Journal)
09:00AM
(The Wall Street Journal)
Jun-19-24 09:30AM
08:48AM
Jun-18-24 06:00PM
04:21PM
(Investor's Business Daily)
12:26PM
11:54AM
10:39AM
09:38AM
09:17AM
(The Wall Street Journal)
07:00AM
07:00AM
Jun-17-24 07:10AM
Jun-12-24 10:35PM
06:00PM
Jun-10-24 06:00AM
Jun-06-24 06:00PM
Jun-03-24 06:58AM
May-31-24 06:00PM
May-29-24 06:05AM
May-27-24 07:17AM
May-24-24 11:31AM
May-23-24 10:05AM
Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Endoscopy, Urology, and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Mahoney Michael F Chairman, President & CEO Sep 05 '24 Option Exercise 16.79 111,886 1,878,261 1,785,764 Sep 06 04:12 PM Mahoney Michael F Chairman, President & CEO Sep 05 '24 Sale 81.17 162,777 13,212,544 1,622,987 Sep 06 04:12 PM MICHAEL F MAHONEY Officer Sep 05 '24 Proposed Sale 81.17 162,777 13,212,533 Sep 05 04:03 PM Carruthers Wendy EVP, Human Resources Sep 03 '24 Option Exercise 19.31 4,263 82,306 44,451 Sep 03 05:29 PM Carruthers Wendy EVP, Human Resources Sep 03 '24 Sale 81.70 6,983 570,511 37,468 Sep 03 05:29 PM WENDY CARRUTHERS Officer Sep 03 '24 Proposed Sale 81.70 6,983 570,511 Sep 03 04:06 PM Fitzgerald Joseph Michael EVP & Group Pres, Cardiology Aug 28 '24 Sale 80.00 14,132 1,130,560 176,355 Aug 29 04:13 PM JOSEPH M FITZGERALD Officer Aug 28 '24 Proposed Sale 80.00 14,132 1,130,560 Aug 28 04:21 PM Butcher Arthur C EVP& Grp Pres, MedSurg & APAC Aug 26 '24 Option Exercise 21.40 4,185 89,542 24,814 Aug 26 04:32 PM Butcher Arthur C EVP& Grp Pres, MedSurg & APAC Aug 26 '24 Sale 79.25 14,012 1,110,515 10,802 Aug 26 04:32 PM ARTHUR C BUTCHER Officer Aug 26 '24 Proposed Sale 79.25 14,012 1,110,514 Aug 26 04:02 PM Carruthers Wendy EVP, Human Resources Aug 01 '24 Option Exercise 19.31 4,263 82,306 47,171 Aug 01 05:13 PM Carruthers Wendy EVP, Human Resources Aug 01 '24 Sale 74.12 6,983 517,580 40,188 Aug 01 05:13 PM WENDY CARRUTHERS Officer Aug 01 '24 Proposed Sale 74.12 6,983 517,580 Aug 01 04:14 PM Carruthers Wendy EVP, Human Resources Jul 01 '24 Option Exercise 19.31 4,263 82,306 49,891 Jul 02 04:13 PM Carruthers Wendy EVP, Human Resources Jul 01 '24 Sale 77.30 6,983 539,786 42,908 Jul 02 04:13 PM Carruthers Wendy EVP, Human Resources Jun 03 '24 Option Exercise 19.31 4,263 82,306 52,611 Jun 03 05:39 PM Carruthers Wendy EVP, Human Resources Jun 03 '24 Sale 75.33 6,983 526,029 45,628 Jun 03 05:39 PM Mirviss Jeffrey B. EVP&Pres, Periph Intervent May 29 '24 Option Exercise 17.26 33,726 582,111 91,824 May 30 04:27 PM Mirviss Jeffrey B. EVP&Pres, Periph Intervent May 29 '24 Sale 75.10 63,802 4,791,447 28,022 May 30 04:27 PM Butcher Arthur C EVP& Grp Pres, MedSurg & APAC May 28 '24 Option Exercise 21.40 4,186 89,565 34,208 May 29 05:04 PM Butcher Arthur C EVP& Grp Pres, MedSurg & APAC May 28 '24 Sale 75.34 14,011 1,055,590 20,197 May 29 05:04 PM Brennan Daniel J. EVP and CFO May 22 '24 Option Exercise 21.33 64,454 1,374,836 335,996 May 23 04:12 PM Brennan Daniel J. EVP and CFO May 22 '24 Sale 75.91 64,454 4,892,819 271,542 May 23 04:12 PM Brennan Daniel J. EVP and CFO May 23 '24 Sale 75.11 47,621 3,576,932 223,921 May 23 04:12 PM Brown Vance R SVP, GC and Corp. Secretary May 21 '24 Option Exercise 24.55 18,037 442,808 50,363 May 23 04:11 PM Brown Vance R SVP, GC and Corp. Secretary May 22 '24 Option Exercise 27.09 15,006 406,513 47,332 May 23 04:11 PM Brown Vance R SVP, GC and Corp. Secretary May 21 '24 Sale 75.60 18,037 1,363,606 32,326 May 23 04:11 PM Brown Vance R SVP, GC and Corp. Secretary May 22 '24 Sale 76.01 15,006 1,140,633 32,326 May 23 04:11 PM Thepaut Eric Francis Yves EVP & Pres, Eur, Mid-East, Afr May 10 '24 Option Exercise 16.31 12,931 210,905 44,353 May 13 04:41 PM Thepaut Eric Francis Yves EVP & Pres, Eur, Mid-East, Afr May 10 '24 Sale 74.14 12,931 958,717 31,422 May 13 04:41 PM Dockendorff Charles J Director May 07 '24 Sale 72.70 3,946 286,874 0 May 08 04:11 PM Sorenson John Bradley EVP, Global Operations May 02 '24 Option Exercise 0.00 4,203 0 54,841 May 06 04:18 PM Butcher Arthur C EVP& Grp Pres, MedSurg & APAC May 02 '24 Option Exercise 0.00 2,102 0 31,039 May 06 04:17 PM Sorenson John Bradley EVP, Global Operations May 01 '24 Option Exercise 17.26 17,587 303,552 68,225 May 02 04:46 PM Sorenson John Bradley EVP, Global Operations May 01 '24 Sale 71.50 17,587 1,257,488 50,638 May 02 04:46 PM Carruthers Wendy EVP, Human Resources May 01 '24 Option Exercise 19.31 4,263 82,306 55,331 May 02 04:42 PM Carruthers Wendy EVP, Human Resources May 01 '24 Sale 71.47 6,983 499,075 48,348 May 02 04:42 PM LUDWIG EDWARD J Director Apr 26 '24 Option Exercise 17.37 9,818 170,539 51,192 Apr 29 04:12 PM LUDWIG EDWARD J Director Apr 26 '24 Sale 73.29 9,818 719,562 41,374 Apr 29 04:12 PM Sorenson John Bradley EVP, Global Operations Apr 01 '24 Option Exercise 16.31 16,351 266,685 66,989 Apr 02 06:57 PM Sorenson John Bradley EVP, Global Operations Apr 01 '24 Sale 69.30 16,351 1,133,069 50,638 Apr 02 06:57 PM Carruthers Wendy EVP, Human Resources Apr 01 '24 Option Exercise 19.31 4,263 82,306 58,051 Apr 02 06:57 PM Carruthers Wendy EVP, Human Resources Apr 01 '24 Sale 68.42 6,983 477,777 51,068 Apr 02 06:57 PM Mirviss Jeffrey B. EVP&Pres, Periph Intervent Mar 18 '24 Sale 66.45 14,506 963,930 58,098 Mar 19 04:41 PM Carruthers Wendy EVP, Human Resources Mar 01 '24 Option Exercise 19.31 4,263 82,306 60,771 Mar 04 06:50 PM Carruthers Wendy EVP, Human Resources Mar 01 '24 Sale 66.35 6,983 463,322 53,788 Mar 04 06:50 PM Butcher Arthur C EVP& Grp Pres, MedSurg & APAC Feb 26 '24 Option Exercise 21.40 4,185 89,542 38,272 Feb 27 04:19 PM Butcher Arthur C EVP& Grp Pres, MedSurg & APAC Feb 26 '24 Sale 67.07 9,335 626,098 28,937 Feb 27 04:19 PM Carruthers Wendy EVP, Human Resources Feb 23 '24 Option Exercise 19.31 4,263 82,306 63,491 Feb 26 04:13 PM Carruthers Wendy EVP, Human Resources Feb 23 '24 Sale 66.89 6,983 467,093 56,508 Feb 26 04:13 PM Mirviss Jeffrey B. EVP&Pres, Periph Intervent Feb 21 '24 Sale 66.35 4,960 329,096 72,604 Feb 22 04:19 PM Thepaut Eric Francis Yves EVP & Pres, Eur, Mid-East, Afr Feb 18 '24 Option Exercise 0.00 2,002 0 31,204 Feb 20 09:05 PM Thepaut Eric Francis Yves EVP & Pres, Eur, Mid-East, Afr Feb 17 '24 Option Exercise 0.00 2,500 0 30,650 Feb 20 09:05 PM Thepaut Eric Francis Yves EVP & Pres, Eur, Mid-East, Afr Feb 16 '24 Option Exercise 0.00 2,263 0 29,461 Feb 20 09:05 PM Sorenson John Bradley EVP, Global Operations Feb 18 '24 Option Exercise 0.00 1,186 0 51,179 Feb 20 09:05 PM Sorenson John Bradley EVP, Global Operations Feb 17 '24 Option Exercise 0.00 1,500 0 50,678 Feb 20 09:05 PM Sorenson John Bradley EVP, Global Operations Feb 16 '24 Option Exercise 0.00 1,273 0 49,759 Feb 20 09:05 PM Monson Jonathan SVP, Global Controller and CAO Feb 18 '24 Option Exercise 0.00 638 0 38,240 Feb 20 09:04 PM Monson Jonathan SVP, Global Controller and CAO Feb 17 '24 Option Exercise 0.00 1,000 0 38,006 Feb 20 09:04 PM Monson Jonathan SVP, Global Controller and CAO Feb 16 '24 Option Exercise 0.00 990 0 37,433 Feb 20 09:04 PM Mirviss Jeffrey B. EVP&Pres, Periph Intervent Feb 18 '24 Option Exercise 0.00 2,817 0 78,849 Feb 20 09:04 PM Mirviss Jeffrey B. EVP&Pres, Periph Intervent Feb 17 '24 Option Exercise 0.00 3,333 0 77,552 Feb 20 09:04 PM Mirviss Jeffrey B. EVP&Pres, Periph Intervent Feb 16 '24 Option Exercise 0.00 2,970 0 75,574 Feb 20 09:04 PM Carruthers Wendy EVP, Human Resources Feb 18 '24 Option Exercise 0.00 1,853 0 63,100 Feb 20 09:03 PM Carruthers Wendy EVP, Human Resources Feb 17 '24 Option Exercise 0.00 2,250 0 62,245 Feb 20 09:03 PM Carruthers Wendy EVP, Human Resources Feb 16 '24 Option Exercise 0.00 2,051 0 60,905 Feb 20 09:03 PM Mahoney Michael F Chairman, President & CEO Feb 18 '24 Option Exercise 0.00 16,307 0 1,681,111 Feb 20 09:03 PM Mahoney Michael F Chairman, President & CEO Feb 17 '24 Option Exercise 0.00 18,333 0 1,672,935 Feb 20 09:03 PM Mahoney Michael F Chairman, President & CEO Feb 16 '24 Option Exercise 0.00 16,265 0 1,661,816 Feb 20 09:03 PM Butcher Arthur C EVP& Grp Pres, MedSurg & APAC Feb 18 '24 Option Exercise 0.00 2,372 0 35,139 Feb 20 09:03 PM Butcher Arthur C EVP& Grp Pres, MedSurg & APAC Feb 17 '24 Option Exercise 0.00 2,833 0 34,024 Feb 20 09:03 PM Butcher Arthur C EVP& Grp Pres, MedSurg & APAC Feb 16 '24 Option Exercise 0.00 2,546 0 32,321 Feb 20 09:03 PM Brennan Daniel J. EVP and CFO Feb 20 '24 Option Exercise 13.08 13,662 178,699 285,204 Feb 20 09:03 PM Brennan Daniel J. EVP and CFO Feb 18 '24 Option Exercise 0.00 3,706 0 273,186 Feb 20 09:03 PM Brennan Daniel J. EVP and CFO Feb 17 '24 Option Exercise 0.00 4,583 0 271,513 Feb 20 09:03 PM Brennan Daniel J. EVP and CFO Feb 16 '24 Option Exercise 0.00 4,243 0 268,812 Feb 20 09:03 PM Brennan Daniel J. EVP and CFO Feb 20 '24 Sale 65.86 13,662 899,779 271,542 Feb 20 09:03 PM Fitzgerald Joseph Michael EVP & Group Pres, Cardiology Feb 18 '24 Option Exercise 0.00 3,706 0 194,696 Feb 20 09:03 PM Fitzgerald Joseph Michael EVP & Group Pres, Cardiology Feb 17 '24 Option Exercise 0.00 4,167 0 193,047 Feb 20 09:03 PM Fitzgerald Joseph Michael EVP & Group Pres, Cardiology Feb 16 '24 Option Exercise 0.00 3,960 0 190,686 Feb 20 09:03 PM Brown Vance R SVP, GC and Corp. Secretary Feb 18 '24 Option Exercise 0.00 741 0 32,544 Feb 20 09:03 PM Brown Vance R SVP, GC and Corp. Secretary Feb 17 '24 Option Exercise 0.00 1,000 0 32,097 Feb 20 09:03 PM Brown Vance R SVP, GC and Corp. Secretary Feb 16 '24 Option Exercise 0.00 1,838 0 31,637 Feb 20 09:03 PM Thepaut Eric Francis Yves EVP & Pres, Eur, Mid-East, Afr Feb 14 '24 Option Exercise 0.00 2,379 0 28,576 Feb 16 04:23 PM Sorenson John Bradley EVP, Global Operations Feb 14 '24 Option Exercise 0.00 2,115 0 49,451 Feb 16 04:23 PM Monson Jonathan SVP, Global Controller and CAO Feb 14 '24 Option Exercise 0.00 1,057 0 36,931 Feb 16 04:22 PM Mirviss Jeffrey B. EVP&Pres, Periph Intervent Feb 14 '24 Option Exercise 0.00 2,776 0 73,870 Feb 16 04:22 PM Mahoney Michael F Chairman, President & CEO Feb 14 '24 Option Exercise 0.00 16,523 0 1,652,879 Feb 16 04:22 PM Carruthers Wendy EVP, Human Resources Feb 14 '24 Option Exercise 0.00 2,115 0 59,793 Feb 16 04:21 PM Fitzgerald Joseph Michael EVP & Group Pres, Cardiology Feb 14 '24 Option Exercise 0.00 4,362 0 188,716 Feb 16 04:21 PM Butcher Arthur C EVP& Grp Pres, MedSurg & APAC Feb 14 '24 Option Exercise 0.00 3,172 0 31,183 Feb 16 04:21 PM Brown Vance R SVP, GC and Corp. Secretary Feb 14 '24 Option Exercise 0.00 1,850 0 30,428 Feb 16 04:21 PM Brennan Daniel J. EVP and CFO Feb 14 '24 Option Exercise 0.00 4,362 0 266,504 Feb 16 04:21 PM LUDWIG EDWARD J Director Feb 13 '24 Option Exercise 17.37 7,000 121,590 48,374 Feb 14 04:23 PM LUDWIG EDWARD J Director Feb 13 '24 Sale 65.03 7,000 455,223 41,374 Feb 14 04:23 PM Fitzgerald Joseph Michael EVP & Group Pres, Cardiology Jan 12 '24 Sale 60.00 11,660 699,600 173,472 Jan 16 04:39 PM Mirviss Jeffrey B. EVP&Pres, Periph Intervent Jan 09 '24 Option Exercise 16.31 15,172 247,455 71,760 Jan 10 05:44 PM Mirviss Jeffrey B. EVP&Pres, Periph Intervent Jan 09 '24 Sale 59.25 15,172 898,941 56,588 Jan 10 05:44 PM Mirviss Jeffrey B. EVP&Pres, Periph Intervent Jan 04 '24 Option Exercise 16.31 15,000 244,650 71,588 Jan 05 04:53 PM
Index S&P 500
P/E 27.77
EPS (ttm) 2.93
Insider Own 1.39%
Shs Outstand 241.71M
Perf Week 0.30%
Market Cap 18.90B
Forward P/E 18.46
EPS next Y 4.41
Insider Trans -3.44%
Shs Float 229.04M
Perf Month 1.71%
Income 701.50M
PEG 3.61
EPS next Q 1.01
Inst Own 98.84%
Short Float 2.45%
Perf Quarter 11.39%
Sales 3.99B
P/S 4.74
EPS this Y 3.13%
Inst Trans -9.78%
Short Ratio 3.63
Perf Half Y 7.77%
Book/sh 21.33
P/B 3.81
EPS next Y 7.97%
ROA 7.70%
Short Interest 5.61M
Perf Year 13.91%
Cash/sh 10.50
P/C 7.75
EPS next 5Y 7.70%
ROE 13.85%
52W Range 64.02 - 84.67
Perf YTD 13.91%
Dividend Est. -
P/FCF 18.45
EPS past 5Y -
ROI 9.39%
52W High -3.87%
Beta 0.98
Dividend TTM -
Quick Ratio 3.32
Sales past 5Y 7.03%
Gross Margin 54.65%
52W Low 27.13%
ATR (14) 1.38
Dividend Ex-Date -
Current Ratio 3.99
EPS Y/Y TTM 51.38%
Oper. Margin 23.14%
RSI (14) 51.15
Volatility 1.51% 1.45%
Employees 6990
Debt/Eq 0.52
Sales Y/Y TTM -1.26%
Profit Margin 17.59%
Recom 2.05
Target Price 88.80
Option/Short Yes / Yes
LT Debt/Eq 0.51
EPS Q/Q 601.52%
Payout 0.00%
Rel Volume 1.64
Prev Close 82.40
Sales Surprise 0.96%
EPS Surprise 4.19%
Sales Q/Q 2.74%
Earnings Jul 29 AMC
Avg Volume 1.54M
Price 81.39
SMA20 0.26%
SMA50 0.92%
SMA200 7.44%
Trades
Volume 2,533,498
Change -1.23%
Date
Action
Analyst
Rating Change
Price Target Change
Jun-27-24 Initiated
Stephens
Overweight
$87
Apr-03-24 Upgrade
Citigroup
Neutral → Buy
$80 → $95
Jul-14-23 Upgrade
Needham
Hold → Buy
$95
Dec-07-22 Initiated
RBC Capital Mkts
Sector Perform
$75
Oct-13-22 Initiated
Mizuho
Buy
$75
Jul-20-22 Initiated
UBS
Neutral
$73
Jul-20-22 Downgrade
BofA Securities
Buy → Neutral
$81 → $75
Jul-18-22 Downgrade
BTIG Research
Buy → Neutral
Apr-25-22 Downgrade
Wells Fargo
Overweight → Equal Weight
$75
Apr-04-22 Downgrade
Evercore ISI
Outperform → In-line
$80
Dec-15-21 Downgrade
Citigroup
Buy → Neutral
$85 → $78
Oct-15-21 Resumed
Cowen
Outperform
$83
Oct-14-21 Initiated
Redburn
Neutral
Jul-06-21 Upgrade
Evercore ISI
In-line → Outperform
$78
Nov-20-20 Downgrade
Needham
Buy → Hold
Nov-05-20 Reiterated
Needham
Buy
$78 → $88
Jun-30-20 Upgrade
Cowen
Market Perform → Outperform
$64
Jun-03-20 Upgrade
Raymond James
Mkt Perform → Outperform
$62
Apr-30-20 Upgrade
SVB Leerink
Mkt Perform → Outperform
$62
Apr-30-20 Reiterated
Needham
Buy
$52 → $60
Show Previous Ratings
Today 05:45PM
Sep-17-24 09:00AM
Sep-11-24 09:50AM
Sep-06-24 09:00AM
Sep-02-24 09:40AM
08:08AM
Loading…
Aug-29-24 08:08AM
Aug-28-24 11:30AM
Aug-26-24 09:00AM
Aug-20-24 08:01AM
Aug-13-24 09:00AM
Aug-09-24 08:20AM
06:51AM
Aug-05-24 09:15AM
Aug-02-24 09:00AM
Aug-01-24 04:40PM
09:30AM
Loading…
Jul-31-24 09:30AM
Jul-30-24 01:04PM
11:20AM
(Thomson Reuters StreetEvents)
08:22AM
08:08AM
04:32AM
Jul-29-24 07:22PM
05:30PM
05:15PM
04:10PM
(Associated Press Finance)
04:01PM
Jul-26-24 11:52AM
05:12AM
Jul-25-24 09:15AM
08:19AM
05:45PM
Loading…
Jul-22-24 05:45PM
Jul-19-24 08:55AM
Jul-17-24 09:10AM
Jul-16-24 05:45PM
09:00AM
Jul-09-24 04:05AM
Jul-08-24 05:45PM
Jul-04-24 08:35AM
Jul-02-24 08:22AM
Jun-27-24 10:25AM
Jun-25-24 05:45PM
09:30AM
Jun-24-24 09:00AM
Jun-11-24 09:00AM
Jun-04-24 12:08PM
May-31-24 09:00AM
May-29-24 09:30AM
May-23-24 08:53AM
06:00AM
May-21-24 08:08AM
May-20-24 09:00AM
May-13-24 09:30AM
May-09-24 08:21AM
May-07-24 11:12AM
09:00AM
May-04-24 01:07AM
May-03-24 12:40PM
12:29PM
11:54AM
10:51AM
09:43AM
07:17AM
(Thomson Reuters StreetEvents)
May-02-24 09:59PM
08:58PM
08:00PM
05:45PM
05:10PM
04:40PM
04:07PM
(Associated Press Finance)
04:01PM
Apr-30-24 06:27AM
Apr-29-24 05:58PM
04:05PM
11:44AM
09:16AM
Apr-25-24 10:01AM
Apr-22-24 05:45PM
Apr-21-24 08:30AM
Apr-19-24 11:30AM
09:00AM
Apr-17-24 11:01AM
Apr-15-24 05:45PM
Apr-12-24 10:45AM
Apr-11-24 02:07PM
09:15AM
Apr-08-24 05:45PM
09:00AM
Apr-03-24 12:10PM
09:54AM
Apr-02-24 05:45PM
08:08AM
Mar-28-24 07:24AM
Mar-27-24 09:00AM
Mar-25-24 05:45PM
Mar-19-24 12:53PM
(The Wall Street Journal)
Mar-18-24 05:45PM
Mar-15-24 07:00PM
09:00AM
Mar-12-24 05:45PM
Mar-06-24 11:15AM
Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products, that focuses on women's health and well-being through early detection and treatment. It operates through the following segments: Breast Health, Diagnostics, GYN Surgical, and Skeletal Health. The Breast Health segment is involved in a portfolio of solutions for breast cancer care primarily in the areas of radiology, breast surgery, pathology and treatment. The Diagnostics segment offers a range of products, which are used primarily to aid in the screening and diagnosis of human diseases. The GYN Surgical segment is involved in hysteroscopic endometrial ablation systems, tissue removal systems, fluid management systems, and laparoscopic tissue ablation systems and tools. The Skeletal Health segment covers the Horizon DXA and the Fluoroscan Insight FD mini C-arm. The company was founded by S. David Ellenbogen and Jay A. Stein in 1985 and is headquartered in Marlborough, MA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Oberton Karleen Marie Chief Financial Officer Aug 29 '24 Option Exercise 40.95 32,805 1,343,214 136,721 Sep 03 04:15 PM Oberton Karleen Marie Chief Financial Officer Aug 29 '24 Sale 80.56 52,679 4,243,662 84,042 Sep 03 04:15 PM Oberton Karleen Marie Officer Aug 29 '24 Proposed Sale 80.56 52,679 4,243,657 Aug 29 04:36 PM Schnittker Brandon Div. President, GYN Surgical Aug 06 '24 Sale 83.11 476 39,559 3,735 Aug 08 04:08 PM Schnittker Brandon Officer Aug 06 '24 Proposed Sale 83.11 476 39,559 Aug 06 04:48 PM COHN BENJAMIN JORDAN Principal Accounting Officer Aug 01 '24 Sale 81.99 5,093 417,570 10,476 Aug 05 04:29 PM MACMILLAN STEPHEN P Chairman, President and CEO Jul 30 '24 Option Exercise 26.21 44,039 1,154,262 1,201,601 Aug 01 04:09 PM MACMILLAN STEPHEN P Chairman, President and CEO Jul 30 '24 Sale 81.70 44,039 3,597,924 1,157,562 Aug 01 04:09 PM COHN BENJAMIN JORDAN Officer Aug 01 '24 Proposed Sale 81.99 5,093 417,574 Aug 01 03:58 PM MACMILLAN STEPHEN P Officer Jul 30 '24 Proposed Sale 81.70 44,039 3,597,894 Jul 30 04:29 PM MACMILLAN STEPHEN P Chairman, President and CEO Jul 17 '24 Option Exercise 26.21 3,672 96,243 1,161,234 Jul 19 04:09 PM MACMILLAN STEPHEN P Chairman, President and CEO Jul 17 '24 Sale 80.13 3,672 294,223 1,157,562 Jul 19 04:09 PM Stamoulis Christiana Director Jul 17 '24 Option Exercise 26.74 9,039 241,703 54,511 Jul 19 04:06 PM Stamoulis Christiana Director Jul 17 '24 Sale 79.50 9,039 718,600 45,472 Jul 19 04:06 PM GARRETT SCOTT T Director Mar 14 '24 Option Exercise 30.93 16,441 508,471 65,052 Mar 15 04:11 PM GARRETT SCOTT T Director Mar 14 '24 Sale 75.50 16,441 1,241,296 48,611 Mar 15 04:11 PM Dockendorff Charles J Director Mar 08 '24 Sale 76.21 1,465 111,648 1,572 Mar 11 06:45 PM CRAWFORD SALLY Director Mar 08 '24 Option Exercise 26.74 9,039 241,703 141,966 Mar 11 06:41 PM CRAWFORD SALLY Director Mar 08 '24 Sale 76.40 9,039 690,607 132,927 Mar 11 06:41 PM Oberton Karleen Marie Chief Financial Officer Jan 29 '24 Sale 75.00 14,940 1,120,500 103,916 Jan 30 04:08 PM Dockendorff Charles J Director Jan 02 '24 Option Exercise 38.44 7,551 290,260 17,482 Jan 04 04:09 PM Dockendorff Charles J Director Jan 02 '24 Sale 72.00 16,017 1,153,224 1,465 Jan 04 04:09 PM GARRETT SCOTT T Director Dec 11 '23 Sale 68.71 10,000 687,116 47,039 Dec 13 04:07 PM MACMILLAN STEPHEN P Chairman, President and CEO Nov 29 '23 Option Exercise 26.21 47,711 1,250,505 1,286,799 Dec 01 04:04 PM MACMILLAN STEPHEN P Chairman, President and CEO Nov 29 '23 Sale 70.41 47,711 3,359,188 1,239,088 Dec 01 04:04 PM Mitchell Essex D Div. President, GYN Surgical Nov 21 '23 Sale 71.85 7,500 538,890 12,827 Nov 24 04:02 PM
Index RUT
P/E 33.52
EPS (ttm) 2.23
Insider Own 1.10%
Shs Outstand 50.79M
Perf Week -1.66%
Market Cap 3.83B
Forward P/E 13.82
EPS next Y 5.41
Insider Trans -6.38%
Shs Float 50.61M
Perf Month -0.77%
Income 114.89M
PEG 2.39
EPS next Q 1.07
Inst Own 109.83%
Short Float 12.04%
Perf Quarter -12.16%
Sales 1.33B
P/S 2.87
EPS this Y 16.11%
Inst Trans -0.55%
Short Ratio 10.28
Perf Half Y -6.80%
Book/sh 17.70
P/B 4.23
EPS next Y 17.73%
ROA 5.10%
Short Interest 6.09M
Perf Year -18.49%
Cash/sh 6.73
P/C 11.12
EPS next 5Y 14.00%
ROE 12.98%
52W Range 70.74 - 97.97
Perf YTD -12.49%
Dividend Est. 1.00 (1.34%)
P/FCF 52.50
EPS past 5Y 17.09%
ROI 5.41%
52W High -23.62%
Beta 0.30
Dividend TTM -
Quick Ratio 2.33
Sales past 5Y 6.80%
Gross Margin 50.96%
52W Low 5.78%
ATR (14) 2.12
Dividend Ex-Date -
Current Ratio 3.76
EPS Y/Y TTM -16.22%
Oper. Margin 14.65%
RSI (14) 43.61
Volatility 2.80% 2.31%
Employees 3657
Debt/Eq 1.35
Sales Y/Y TTM 9.47%
Profit Margin 8.61%
Recom 1.73
Target Price 109.80
Option/Short Yes / Yes
LT Debt/Eq 1.35
EPS Q/Q -6.91%
Payout 0.00%
Rel Volume 1.74
Prev Close 75.08
Sales Surprise 0.33%
EPS Surprise 1.44%
Sales Q/Q 7.98%
Earnings Aug 08 BMO
Avg Volume 592.44K
Price 74.83
SMA20 -0.31%
SMA50 -7.39%
SMA200 -9.82%
Trades
Volume 1,031,398
Change -0.33%
Date
Action
Analyst
Rating Change
Price Target Change
Sep-13-24 Initiated
CL King
Buy
$116
Sep-11-24 Initiated
BofA Securities
Neutral
$85
Sep-10-24 Initiated
BTIG Research
Buy
$112
Jun-12-24 Upgrade
Needham
Hold → Buy
$112
Oct-13-22 Initiated
Mizuho
Buy
$90
Jan-27-22 Downgrade
Needham
Buy → Hold
Dec-15-21 Downgrade
Citigroup
Buy → Neutral
$75 → $59
Aug-17-21 Resumed
Raymond James
Outperform
$75
Jun-17-21 Initiated
Citigroup
Buy
$75
May-14-21 Upgrade
CJS Securities
Market Perform → Market Outperform
Apr-20-21 Downgrade
Morgan Stanley
Overweight → Equal-Weight
Apr-19-21 Downgrade
CJS Securities
Market Outperform → Market Perform
Feb-03-21 Upgrade
Barrington Research
Mkt Perform → Outperform
$140
Jan-21-21 Downgrade
Barrington Research
Outperform → Mkt Perform
Nov-05-20 Upgrade
Barrington Research
Mkt Perform → Outperform
$106
May-06-20 Downgrade
Barrington Research
Outperform → Mkt Perform
Mar-31-20 Upgrade
CJS Securities
Market Perform → Market Outperform
Jan-10-20 Initiated
Needham
Buy
$138
Aug-07-19 Reiterated
Barrington Research
Outperform
$116 → $139
May-14-19 Upgrade
Raymond James
Mkt Perform → Outperform
$110
Show Previous Ratings
Today 12:54AM
Sep-02-24 09:35AM
Aug-23-24 09:22AM
Aug-16-24 09:08AM
06:33AM
06:30AM
Loading…
Aug-15-24 06:30AM
Aug-12-24 07:47AM
Aug-09-24 09:40AM
09:35AM
Aug-08-24 07:25AM
06:25AM
(Associated Press Finance)
06:00AM
Aug-07-24 09:55AM
09:40AM
Aug-01-24 07:00AM
06:00AM
Loading…
Jul-30-24 06:00AM
Jul-29-24 10:20AM
Jul-16-24 09:45AM
Jul-12-24 11:38AM
Jul-10-24 09:55AM
Jul-08-24 04:05PM
Jun-27-24 09:35AM
Jun-19-24 01:26PM
04:52AM
Jun-18-24 04:15PM
Jun-14-24 09:40AM
Jun-13-24 10:19AM
Jun-03-24 09:45AM
May-30-24 02:41AM
02:41AM
09:40AM
Loading…
May-29-24 09:40AM
May-27-24 12:45PM
May-24-24 09:55AM
May-23-24 12:00PM
06:00AM
May-22-24 09:13AM
02:06AM
May-21-24 04:05PM
May-17-24 12:00PM
10:20AM
May-14-24 09:15AM
May-13-24 09:40AM
May-10-24 03:57PM
12:41PM
10:53AM
10:37AM
May-09-24 10:55AM
09:30AM
07:20AM
06:39AM
06:28AM
(Associated Press Finance)
06:00AM
May-08-24 09:15PM
May-06-24 09:16AM
May-01-24 11:51AM
Apr-12-24 09:03AM
Apr-10-24 04:58PM
Apr-08-24 03:20PM
Apr-05-24 09:48AM
Apr-04-24 06:30AM
Apr-01-24 08:00AM
Mar-29-24 09:30AM
Mar-11-24 09:30AM
Mar-06-24 06:54AM
Mar-05-24 06:18AM
06:00AM
Feb-27-24 12:00PM
Feb-21-24 05:57PM
05:55PM
Feb-18-24 01:26PM
Feb-09-24 10:39AM
10:34AM
09:40AM
Feb-08-24 10:00PM
(Thomson Reuters StreetEvents)
09:30AM
07:10AM
06:33AM
06:10AM
(Associated Press Finance)
06:00AM
Feb-05-24 09:16AM
Feb-01-24 10:00AM
Jan-31-24 12:45PM
Jan-18-24 09:40AM
Jan-12-24 09:45AM
Jan-11-24 04:05PM
Jan-03-24 01:56PM
Dec-29-23 12:34PM
Dec-25-23 09:30AM
09:30AM
Dec-18-23 09:45AM
Dec-15-23 12:45PM
Dec-12-23 06:00AM
Dec-07-23 04:05PM
Dec-05-23 09:40AM
Dec-04-23 12:09PM
Nov-30-23 09:35AM
Nov-28-23 12:45PM
Nov-27-23 12:39PM
10:46AM
Nov-23-23 09:45AM
Haemonetics Corp. engages in the development and distribution of hematology products and solutions. It operates through the following segments: Plasma, Blood Center, and Hospital. The Plasma segment offers automated plasma collection and donor management software systems. The Blood Center segment provides solutions for donor collection centers' ability to acquire blood, filter blood, and separate blood components. The Hospital segment includes hemostasis management, cell salvage, and transfusion management services that help decision makers in hospitals optimize blood acquisition, storage, and usage in critical settings. The company was founded by Allen Latham, Jr. in 1971 and is headquartered in Boston, MA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Strong Stewart W President, Global Hospital Jul 26 '24 Sale 91.15 4,312 393,039 18,196 Jul 29 05:03 PM Strong Stewart W Officer Jul 26 '24 Proposed Sale 91.15 4,312 393,039 Jul 26 09:47 AM Lingamneni Anila EVP, Chief Technology Officer Jul 11 '24 Sale 90.00 2,136 192,240 21,410 Jul 15 04:27 PM Lingamneni Anila EVP, Chief Technology Officer Jul 12 '24 Sale 90.00 79 7,110 21,331 Jul 15 04:27 PM Simon, Christopher President & CEO Jun 06 '24 Option Exercise 41.64 104,516 4,352,046 433,877 Jun 07 04:15 PM Basil Michelle L EVP and General Counsel May 29 '24 Sale 88.08 12,990 1,144,208 31,257 May 29 05:38 PM Strong Stewart W President, Global Hospital May 29 '24 Sale 87.53 8,857 775,253 18,196 May 29 05:27 PM Strong Stewart W President, Global Hospital May 20 '24 Option Exercise 56.57 2,241 126,773 20,437 May 21 06:01 PM Strong Stewart W President, Global Hospital May 20 '24 Sale 95.11 686 65,245 18,196 May 21 06:01 PM Llorens Josep EVP, Global Manufacturing May 20 '24 Sale 95.08 987 93,844 21,310 May 21 05:52 PM Llorens Josep EVP, Global Manufacturing May 17 '24 Sale 94.82 822 77,942 16,350 May 21 05:52 PM Basil Michelle L EVP and General Counsel May 20 '24 Sale 95.08 1,604 152,508 31,257 May 21 05:46 PM Basil Michelle L EVP and General Counsel May 17 '24 Sale 95.00 1,073 101,935 29,352 May 21 05:46 PM Strong Stewart W President, Global Hospital May 16 '24 Option Exercise 57.60 2,410 138,816 18,018 May 17 05:11 PM Strong Stewart W President, Global Hospital May 16 '24 Sale 96.04 733 70,397 15,608 May 17 05:11 PM Basil Michelle L EVP and General Counsel May 16 '24 Sale 96.14 985 94,698 30,425 May 17 05:02 PM Llorens Josep EVP, Global Manufacturing May 16 '24 Sale 96.14 770 74,028 17,172 May 17 04:55 PM Lingamneni Anila EVP, Chief Technology Officer May 06 '24 Sale 95.00 2,305 218,975 12,295 May 08 04:21 PM
Index S&P 500
P/E 29.33
EPS (ttm) 5.20
Insider Own 0.79%
Shs Outstand 174.60M
Perf Week 1.59%
Market Cap 26.45B
Forward P/E 21.83
EPS next Y 6.98
Insider Trans -0.43%
Shs Float 172.17M
Perf Month -3.42%
Income 913.00M
PEG -
EPS next Q 1.57
Inst Own 89.29%
Short Float 1.25%
Perf Quarter 11.26%
Sales 5.00B
P/S 5.29
EPS this Y -25.81%
Inst Trans -3.18%
Short Ratio 1.75
Perf Half Y -1.18%
Book/sh 30.14
P/B 5.06
EPS next Y 12.99%
ROA 10.06%
Short Interest 2.16M
Perf Year 15.00%
Cash/sh 9.40
P/C 16.21
EPS next 5Y -2.04%
ROE 18.03%
52W Range 118.57 - 162.51
Perf YTD -4.19%
Dividend Est. -
P/FCF 28.85
EPS past 5Y 46.88%
ROI 13.79%
52W High -6.21%
Beta 0.97
Dividend TTM -
Quick Ratio 1.39
Sales past 5Y 7.32%
Gross Margin 63.26%
52W Low 28.55%
ATR (14) 3.79
Dividend Ex-Date -
Current Ratio 2.03
EPS Y/Y TTM -17.55%
Oper. Margin 18.91%
RSI (14) 59.13
Volatility 1.80% 2.09%
Employees 14900
Debt/Eq 0.39
Sales Y/Y TTM -10.60%
Profit Margin 18.25%
Recom 1.93
Target Price 169.73
Option/Short Yes / Yes
LT Debt/Eq 0.27
EPS Q/Q 38.16%
Payout 0.00%
Rel Volume 1.46
Prev Close 155.38
Sales Surprise 1.92%
EPS Surprise 16.37%
Sales Q/Q -11.94%
Earnings Aug 20 AMC
Avg Volume 1.24M
Price 152.42
SMA20 1.27%
SMA50 7.84%
SMA200 3.30%
Trades
Volume 1,806,406
Change -1.91%
Date
Action
Analyst
Rating Change
Price Target Change
Jul-23-24 Initiated
Vertical Research
Buy
$175
Feb-15-24 Downgrade
JP Morgan
Overweight → Neutral
$184 → $170
Sep-15-23 Upgrade
Morgan Stanley
Equal-Weight → Overweight
$165
Sep-05-23 Upgrade
Goldman
Neutral → Buy
$146 → $164
Aug-18-23 Downgrade
Barclays
Overweight → Equal Weight
$204 → $144
Aug-14-23 Downgrade
BofA Securities
Neutral → Underperform
$163 → $148
Jun-30-23 Initiated
Citigroup
Buy
$200
Jan-11-23 Downgrade
Goldman
Buy → Neutral
$196 → $189
Jan-10-23 Upgrade
Barclays
Equal Weight → Overweight
$175 → $202
Nov-03-22 Initiated
Wells Fargo
Overweight
$200
Mar-11-22 Upgrade
Deutsche Bank
Hold → Buy
$176
Dec-08-21 Initiated
Morgan Stanley
Equal-Weight
$200
Nov-23-21 Reiterated
Jefferies
Buy
$190 → $220
Nov-23-21 Reiterated
Credit Suisse
Outperform
$175 → $210
Nov-23-21 Reiterated
Citigroup
Buy
$190 → $220
Jul-02-21 Downgrade
Barclays
Overweight → Equal Weight
$162
Jan-25-21 Downgrade
Deutsche Bank
Buy → Hold
$150
Nov-16-20 Initiated
Deutsche Bank
Buy
$129
Sep-16-20 Initiated
UBS
Buy
$133
Aug-13-20 Upgrade
Goldman
Neutral → Buy
$120
Show Previous Ratings
Today 04:51AM
Sep-19-24 04:05PM
04:05PM
11:30AM
11:00AM
11:00AM
Loading…
Sep-18-24 11:00AM
Sep-17-24 01:45PM
11:00AM
09:00AM
Sep-13-24 11:00AM
Sep-12-24 11:00AM
Sep-11-24 11:00AM
Sep-04-24 11:00AM
03:35AM
Sep-02-24 03:45AM
01:12AM
Loading…
Aug-30-24 01:12AM
Aug-28-24 11:00AM
Aug-24-24 12:00PM
Aug-23-24 07:18AM
Aug-22-24 08:00AM
Aug-21-24 06:32PM
(Morningstar Research) +13.88%
05:26PM
04:46PM
04:31PM
04:16PM
03:19PM
01:13PM
12:06PM
09:46AM
Aug-20-24 07:01PM
05:43PM
Loading…
05:43PM
05:30PM
05:15PM
04:15PM
04:13PM
(Associated Press Finance)
04:05PM
Aug-19-24 09:01AM
03:01AM
Aug-15-24 09:15AM
Aug-14-24 11:28AM
11:00AM
10:27AM
Aug-13-24 11:00AM
Aug-06-24 11:00AM
Aug-05-24 04:32AM
Jul-30-24 08:00AM
Jul-29-24 11:00AM
Jul-24-24 06:27PM
11:00AM
Jul-23-24 11:00AM
Jul-22-24 11:00AM
Jul-21-24 06:07AM
Jul-18-24 11:00AM
Jul-17-24 01:14PM
Jul-16-24 06:34PM
11:00AM
Jul-15-24 11:00AM
Jul-12-24 11:59AM
Jul-11-24 11:00AM
Jul-10-24 12:01PM
04:51AM
Jul-09-24 12:01PM
Jul-05-24 06:29AM
Jul-03-24 05:15AM
Jul-02-24 03:45AM
Jul-01-24 09:45AM
Jun-28-24 11:00AM
Jun-27-24 11:00AM
Jun-26-24 11:17AM
Jun-25-24 11:00AM
Jun-19-24 11:30AM
06:30AM
Jun-13-24 11:00AM
Jun-11-24 11:00AM
Jun-06-24 11:00AM
Jun-04-24 06:29PM
11:00AM
Jun-01-24 01:02AM
May-30-24 11:00AM
May-28-24 08:00AM
May-21-24 04:50PM
04:22PM
03:00PM
01:16PM
12:58PM
12:41PM
10:56AM
10:11AM
08:08AM
07:27AM
07:17AM
07:17AM
06:56AM
(Thomson Reuters StreetEvents)
May-20-24 11:46PM
08:53PM
06:00PM
05:21PM
05:15PM
04:29PM
04:17PM
(Associated Press Finance)
Keysight Technologies, Inc. engages in the provision of electronic design and test solutions that are used in the design, development, manufacture, installation, deployment, validation, optimization and secure operation of electronics systems to communications, networking and electronics industries. It operates through the following segments: Communications Solutions Group, and Electronic Industrial Solutions Group. The Communications Solutions Group segment serves customers spanning the worldwide commercial communications end market, which includes internet infrastructure, and the aerospace, defense and government end market. The Electronic Industrial Solutions Group segment offers test and measurement solutions across a broad set of electronic industrial end markets, focusing on high-growth applications in the automotive and energy industry and measurement solutions for semiconductor design and manufacturing, consumer electronics, education, and general electronics manufacturing. The company was founded by William R. Hewlett and David Packard in 1937 and is headquartered in Santa Rosa, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
HAMADA RICHARD P Director Aug 22 '24 Sale 156.00 1,632 254,592 42,160 Aug 26 07:17 PM HAMADA RICHARD P Director Aug 22 '24 Proposed Sale 156.00 1,632 254,592 Aug 22 02:30 PM POOLE LISA M. VP and Controller Jun 17 '24 Sale 136.45 440 60,038 3,913 Jun 18 07:31 PM Stephens Kevin A Director May 28 '24 Buy 143.35 460 65,941 7,681 May 30 04:28 PM NARAYANAN KAILASH SVP Mar 26 '24 Sale 152.88 4,300 657,384 29,156 Mar 28 04:17 PM Nersesian Ronald S. Director Dec 27 '23 Sale 159.82 29,672 4,742,179 296,619 Dec 28 04:04 PM NARAYANAN KAILASH SVP Dec 15 '23 Sale 159.16 1,006 160,117 33,456 Dec 18 05:36 PM Dougherty Neil EVP and CFO Dec 15 '23 Sale 159.35 14,686 2,340,214 106,793 Dec 18 05:36 PM Ee Huei Sin SVP Dec 14 '23 Sale 156.47 5,000 782,325 44,317 Dec 15 05:45 PM PAGE JOHN SVP Dec 13 '23 Sale 150.00 6,155 923,250 36,767 Dec 15 05:44 PM Li Jeffrey K SVP and Secretary Dec 13 '23 Sale 150.00 4,748 712,200 28,174 Dec 15 05:44 PM Gooi Soon Chai SVP Dec 12 '23 Sale 148.03 14,900 2,205,592 239,488 Dec 13 04:22 PM CULLEN JAMES Director Dec 11 '23 Sale 146.47 4,869 713,154 20,730 Dec 13 04:21 PM Dhanasekaran Satish President and CEO Dec 06 '23 Sale 140.00 11,138 1,559,320 105,139 Dec 08 04:13 PM Dhanasekaran Satish President and CEO Nov 27 '23 Sale 134.90 7,275 981,398 116,277 Nov 29 04:16 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite